33 completed, 9 unknown, 4 terminated, 2 active not recruiting. 6 Not applicable, 6 Phase 2, 6 Phase 3, 4 Phase 4, 2 Phase 1.
Follow No Drug: new trials by email Literature Review of No Drug trials Research Report on No Drug
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC No Drug - NSCLC | Not yet recruiting | Nanjing Tianyinshan Hospital | 1000 | 2026-04-10 | 2026-04-07 | |
| Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy monoclonal CD-20 antibodies, No Drug, Other treatment - Multiple Sclerosis, Pregnancy | Not yet recruiting | Region Stockholm | 111 | 2026-02-01 | 2025-11-25 | |
| Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer No drug - Triple Negative Breast Cancer | Active not recruiting | Daiichi Sankyo | 760 | 2025-09-01 | 2026-10-16 | |
| Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i No drug - Advanced/Metastatic HER2-negative Breast Cancer | Completed | Daiichi Sankyo | 1415 | 2025-04-14 | 2025-10-07 | |
| Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN) No drug - Non-small Cell Lung Cancer | Recruiting | Daiichi Sankyo | 150 | 2025-02-21 | 2026-08-18 | |
| A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study) No Drug - Diabetic Peripheral Neuropathic Pain | Completed | Daiichi Sankyo | 721 | 2025-01-24 | 2026-10-14 | |
| Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan No drug - HER2-positive Breast Cancer | Completed | Daiichi Sankyo | 228 | 2025-01-20 | 2025-07-08 | |
| Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China No Drug - Diabetic Peripheral Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy | Completed | Daiichi Sankyo | 1271 | 2024-08-16 | 2025-07-23 | |
| A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments No drug - Non-small Cell Lung Cancer (NSCLC) | Completed | Daiichi Sankyo | 1041 | 2024-08-15 | 2025-08-03 | |
| A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China No drug - Gastric Cancer, Gastroesophageal Junction Cancer | Completed | Daiichi Sankyo | 805 | 2024-08-15 | 2025-08-21 | |
| A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer No drug - Advanced/Metastatic NSCLC, Advanced/Metastatic HER2-negative Breast Cancer | Completed | Daiichi Sankyo | 13759 | 2024-07-09 | 2025-03-19 | |
| Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients Alpha Lipoic Acid 600 MG Oral Capsule - Breast Cancer, Alpha Lipoic Acid | Phase 4 | Unknown | Ain Shams University | 92 | 2024-04-01 | 2024-05-09 |
| Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment No drug - Non-small Cell Lung Cancer, Lung Cancer | Completed | Daiichi Sankyo | 22517 | 2024-03-01 | 2024-12-09 | |
| Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes Baseline surveys, Cognitive testing and EMAs, Actiwatch, suvorexant (or placebo) - Insomnia | Phase 2 | Completed | University of Maryland, Baltimore | 40 | 2023-10-09 | 2025-10-30 |
| Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer No drug - Hormone-receptor-positive Breast Cancer, HER2-low Breast Cancer | Completed | Daiichi Sankyo | 927 | 2023-07-31 | 2024-02-26 | |
| An Observational Study to Learn More About NTRK Gene Fusion Positive in Solid Tumor in Japan No Drug - Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion | Completed | Bayer | 46621 | 2023-03-10 | 2023-10-25 | |
| Inducing Immune Quiescence the Genital Tract With ASA ASA 81mg, Control Group, ASA 325mg - HIV | Not applicable | Unknown | University of Manitoba | 300 | 2022-01-10 | 2023-10-16 |
| Combined On-demand Sildenafil Citrate and Tramadol Hydrochloride for Treatment of Premature Ejaculation Sildenafil 50 mg, Placebo, Tramadol Hydrochloride 100 MG - Premature Ejaculation | Phase 4 | Unknown | Assiut University | 160 | 2021-12-30 | 2022-01-10 |
| Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II no drug - Indirect Calorimetry | Unknown | University of Liege | 60 | 2021-08-31 | 2023-06-27 | |
| Project Affinity: Excess Cancer Blood Testing No drug - Cancer | Completed | Entia Ltd | 613 | 2021-04-15 | 2022-09-29 |
Showing 20 of 51. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (5) · Atrial Fibrillation (2) · Breast Neoplasms (2) · Choroidal Neovascularization (2) · Lung Neoplasms (2) · Acquired Immunodeficiency Syndrome (1) · Amyloid Neuropathies, Familial (1) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Colorectal Neoplasms (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Foot (1) · Diabetic Retinopathy (1) · Endometriosis (1)
Daiichi Sankyo (14) · Bayer (11) · Far Eastern Memorial Hospital (2) · Pfizer (2) · Ain Shams University (1) · Assiut University (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Ben-Gurion University of the Negev (1) · Centre Hospitalier Régional d'Orléans (1) · Centre Oscar Lambret (1) · Entia Ltd (1) · Lithuanian University of Health Sciences (1) · Nanjing Tianyinshan Hospital (1) · Ramathibodi Hospital (1) · Region Stockholm (1)
United States (14) · China (7) · France (4) · Germany (4) · Italy (4) · Spain (4) · Sweden (4) · Taiwan (4) · United Kingdom (4) · Poland (3) · Belgium (2) · Brazil (2) · Bulgaria (2) · Czechia (2) · Hungary (2)
Adriana Maciel, MsC (1) · Cenk Sahan, MD (1) · Claudio Maffeis, MD (1) · Emerson M Wickwire, PhD (1) · Fernanda Nogueira, Bachelor (1) · Katharina Fink, MD, Dr. med. (1)
PMID 12457622, PMID 15135924, PMID 15911704, PMID 17131349, PMID 19687359, PMID 19786984, PMID 21073761, PMID 21600374, PMID 22440336, PMID 22619725, PMID 22964265, PMID 24002370, PMID 24227635, PMID 24495468, PMID 24606242, PMID 24721800, PMID 24777126, PMID 25054436, PMID 25361834, PMID 25680558, PMID 25819852, PMID 26169611, PMID 28297712, PMID 29291932, PMID 29884234, PMID 30073497, PMID 30264707, PMID 30721699, PMID 31651976, PMID 32554133, PMID 32673517, PMID 33705788, PMID 33985854, PMID 34562992, PMID 35510329, PMID 35596774, PMID 36382727, PMID 38925616, PMID 40788612, PMID 41490112, PMID 41849003, PMID 42217113, PMID 42667570, PMID 9378235
2009 (1), 2014 (1), UL1TR000445 (1)